Workshop
IMI
1. Identification, Characterization, and Clinical Use of Bacteriophages Against Achromobacter Infection in Cystic Fibrosis – Presented by Justin Massey
2. Exploring the Effects of Highly Effective Modulator Therapies on Infection, Inflammation, and Olfaction in the Sinuses of Adults with Cystic Fibrosis – Presented by Shannon Robins
3. Sublethal Doses of the Microbicidal Compound Hypothiocyanite Convert Methicillin-Resistant Staphylococcus aureus to Small Colony Variants – Presented by Jacob Fairholm
4. Nitric Oxide Enhances Antimicrobial Effects of Clofazimine Against Mycobacterium abscessus – Presented by Nathan Thomas
5. CMTX-101, a Pathogen-Agnostic Anti-Biofilm Antibody, Reduces P. aeruginosa Burden and Inflammation and Preserves Lung Function in a Highly Treated CF Population: Results from a Phase 1b/2a Trial – Presented by Jerry Nick
Joy E. Gibson
Children's Hospital Los Angeles
Kristin Hudock, MD, MSTR
University of Cincinnati & Cincinnati Children's
Justin K. Massey, MD
UPMC Children's Hospital of Pittsburgh
Shannon Robins
Dartmouth Hitchcock Medical Center
Jacob D. Fairholm, Masters of Science
University of Georgia
Nathan I. Thomas, MS
Children's Hospital Los Angeles
Jerry A. Nick, MD
National Jewish Health